ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that it plans to move its U.S. Healthcare headquarters, currently located in Rockland, Mass., to Boston’s Seaport district. ​

马萨诸塞州罗克兰-（商业线）-美国和加拿大达姆施塔特默克KGaA的医疗保健业务EMD Serono今天宣布计划将目前位于马萨诸塞州罗克兰的美国医疗保健总部搬到波士顿的海港区。​

“The U.S. market is critical to our continued success as a global specialty innovator. Today we deliver important therapeutic options to more than 150,000 oncology, multiple sclerosis (MS) and fertility patients in the U.S.,” said Chris Round, President of EMD Serono. “This move serves as an important milestone in our journey to bring further innovation to address high unmet medical needs in areas where patients rely on us.

“美国市场对于我们作为全球专业创新者的持续成功至关重要。今天，我们为美国超过15万名肿瘤学，多发性硬化症（MS）和生育患者提供了重要的治疗选择。”EMD Serono总裁克里斯·劳德说。“这一举措是我们进一步创新以解决患者依赖我们的领域未满足的医疗需求的重要里程碑。

Our vibrant new office setting in the Seaport district will bring EMD Serono into the center of the globally leading healthcare innovation hub to support our future growth.”.

我们在Seaport地区充满活力的新办公环境将使EMD Serono成为全球领先的医疗保健创新中心的中心，以支持我们未来的发展“。

The company plans to introduce one new product or major indication every 1.5 years on average, beginning with two potential U.S. launches in 2025. EMD Serono remains committed to optimizing its impact across three therapeutic areas – in Neurology & Immunology, Oncology, and Fertility, which includes:.

该公司计划平均每1。5年推出一项新产品或主要指示，从2025年美国可能推出的两次开始。EMD Serono仍然致力于优化其在三个治疗领域的影响-神经病学和免疫学，肿瘤学和生育能力，其中包括：。

2 available oncology products across 5 indications in the U.S.

美国5种适应症中有2种可用的肿瘤产品。

20+ years of expertise in MS

20多年的MS专业知识

25+ years of leadership in Fertility

生育领导25年以上

“I am thrilled that EMD Serono's U.S. Healthcare headquarters will move to the Seaport in Summer 2024. Boston continues to be the leading global healthcare hub, and we are excited to welcome EMD Serono employees to our community,” said Boston Mayor, Michelle Wu.

“我很高兴EMD Serono的美国医疗保健总部将于2024年夏天搬到海港。波士顿市长米歇尔·吴（Michelle Wu）说，波士顿仍然是领先的全球医疗保健中心，我们很高兴欢迎EMD Serono员工来到我们的社区。

The U.S. Healthcare business plans to move to 200 Pier 4 Boulevard in Boston’s Seaport district in summer 2024. In addition to the Seaport site, the Healthcare business will maintain its global Research and Development hub in Billerica, Mass.

美国医疗保健业务计划于2024年夏天搬到波士顿海港区200码头4大道。除了海港站点外，医疗保健业务还将在马萨诸塞州比勒里卡维持其全球研发中心。

The company is currently designing the offices in keeping with the Merck KGaA, Darmstadt, Germany global footprint of inclusive, accessible, and sustainable workplaces that foster collaboration and support a variety of hybrid working arrangements. The company is targeting LEED and WELL certifications in its design in alignment with Merck KGaA, Darmstadt, Germany’s sustainability goals..

该公司目前正在设计该办公室，以保持与德国达姆施塔特的默克公司（Merck KGaA）在全球范围内的包容性，可访问性和可持续性工作场所的合作，促进合作并支持各种混合工作安排。该公司的目标是与德国达姆施塔特的默克公司（Merck KGaA）的可持续发展目标保持一致。。

About EMD Serono, Inc.

关于EMD Serono，Inc。

EMD Serono – the healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada - aspires to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. The business is imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs.

EMD Serono-Merck KGaA，德国达姆施塔特在美国和加拿大的医疗保健业务-致力于为患有不孕症，多发性硬化症和癌症等难以治疗的疾病的人创造，改善和延长寿命。该业务正在通过努力将分子的发现转化为对严重未满足医疗需求的人有潜在意义的结果来想象医疗保健的未来。

EMD Serono’s global roots go back more than 350 years with Merck KGaA, Darmstadt, Germany and more than 25 years within Massachusetts. Today, the business has approximately 1,050 employees around the country with commercial, medical, clinical and research operations in Massachusetts. ​.

EMD Serono的全球根源可追溯到德国达姆施塔特的默克KGaA超过350年，以及马萨诸塞州超过25年。今天，该业务在全国约有1050名员工，在马萨诸塞州拥有商业，医疗，临床和研究业务。​.

About Merck KGaA, Darmstadt, Germany

关于德国达姆施塔特默克公司

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. Around 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere.

德国达姆施塔特的默克公司是一家领先的科技公司，在生命科学，医疗保健和电子领域开展业务。大约6万名员工通过创造更多快乐和可持续的生活方式，每天为数百万人的生活做出积极的改变。从提供加速药物开发和制造的产品和服务，以及发现治疗最具挑战性疾病的独特方法到实现设备智能，公司无处不在。

In 2022, Merck KGaA, Darmstadt, Germany, generated sales of more than €22 billion in 66 countries..

2022年，德国达姆施塔特的默克公司在66个国家实现了超过220亿欧元的销售额。。

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics.

该公司拥有国际名称和商标“Merck”的全球权利。唯一的例外是美国和加拿大，德国达姆施塔特的默克公司的商业部门在生命科学领域以MilliporeSigma，医疗保健领域的EMD Serono和电子领域的EMD Electronics运作。

Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company..

自1668年成立以来，科学探索和负责任的创业一直是公司技术和科学进步的关键。至今，创始家族仍然是上市公司的多数所有者。。